Hepatitis C, table 2, Prospective Study of InterferonTherapy for Compensated Cirrhotic Patients With Chronic HepatitisC

Prospective Study of Interferon Therapy for Compensated Cirrhotic Patients With Chronic Hepatitis C by Monitoring Serum Hepatitis C RNA

table 2. Efficacy of IFN Therapy on Cirrhotic Patients

End-of-Treatment Response (ETR)
	Randomized		All Patients Randomized	Nonrandomized	Total
	+16 Weeks	+32 Weeks	All Patients Randomized	Nonrandomized	Total

Number of patients	37	36	73	84	157
Virological	27 (73%)	27 (75%)	54 (74%)^*	6 (7%)	60 (38%)
Biochemical	15 (41%)	16 (44%)	31 (42%)^*	15 (18%)	46 (29%)
Sustained Response (SR)
	Randomized		All Patients Randomized	Nonrandomized	Total
	+16 Weeks	+32 Weeks	All Patients Randomized	Nonrandomized	Total
Number of patients	37	36	73	84	157
Virological	12 (32%)	18 (50%)	30 (41%)^*	2 (2%)	32 (20%)
Biochemical	12 (32%)	16 (44%)	28 (38%)^*	9 (11%)	37 (24%)

^* P < .01; ² test (randomized group vs. nonrandomized group).